Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market 2019 Size, Share, Growth | Global Industry Research Report, 2026

SKU ID : FBUIN-14688181 | Publishing Date : 01-Sep-2019 | No. of pages : 0

Keyplayers in Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market 2019 Size, Share, Growth | Global Industry Research Report, 2026

Some of the major companies that are present in the global alpha-1 antitrypsin deficiency treatment market are Grifols S.A., CSL Limited, Baxter, Kamada Ltd., Takeda Pharmaceutical Company Limited, Abeona Therapeutics Inc., and other players.
PRICE
4850
8850

6850


  • market Reports market Reports